Extract:
“SecurePort IV (Adhezion Biomedical) is a cyanoacrylate tissue adhesive intended for use in people having a percutaneous catheter inserted. Percutaneous catheters are associated with complications such as migration or dislodgement of the catheter, bleeding around the insertion site and infection. Specifically, SecurePort IV is a 2-octyl-cyanoacrylate tissue adhesive, and the company claims the device offers enhanced properties for patients and clinicians. SecurePort IV seals and secures the insertion site and uses a formulation to reduce catheter-related infections. The formulation has antimicrobial properties, which the company claims reduces the ability of bacteria to migrate into the bloodstream and tissues. Each applicator holds 0.15 ml of SecurePort IV and can distribute controlled amounts of product. After placement of a line, 1 to 2 drops of SecurePort IV are applied at the insertion site, underneath catheter hubs and over any sutures to increase dressing adherence and reduce the risk of infection. The adhesive remains active for up to 7 days which limits the need for regular dressing changes. SecurePort IV has been tested for compatibility with a wide range of catheters and can be used alone as a securement device or in addition to currently available devices.”
Reference:NICE (2022) SecurePort IV tissue adhesive for use with percutaneous catheters: Medtech innovation briefing Published: 15 March 2022.